Dyadic International, Inc. operates as a U.S.-based biotechnology platform company, specializing in the development, production, and commercialization of enzymes and other proteins. Its core activities are underpinned by a patented and proprietary C1 platform, alongside other advanced technologies. This technological f…
An institutional-grade, numbers-driven thesis on DYAI — generated on demand from live fundamentals, scores and forecast.
Member feature · 7-day free trial · no charge today · cancel anytime
As of July 4, 2026, TradersQuant's model rates Dyadic International, Inc. (DYAI) 52/100 with a 12-month base-case forecast of $3.00 — +219.0% versus the current price of $0.94. Dyadic International, Inc. trades at $0.94 in the Healthcare sector, with a market capitalisation of $34.3M. The score blends valuation, growth, earnings quality and momentum into a single grade.
The 12-month analyst consensus price target for DYAI is $3.00, implying +219.0% versus the current price. The model's 12-month scenario range runs from $0.73 (bear) to $1.11 (bull), with a base case of $0.89.
On the fundamentals, Dyadic International shows a P/E of -4.4, trailing revenue of $3.1M, revenue growth of -64.7% YoY. This page also tracks DYAI's short interest, institutional (smart-money) positioning and the options market — the same cross-signal view institutions watch.
DYAI currently carries a TradersQuant composite score of 52/100, which we read as a neutral-to-watch signal. The Wall-Street analyst consensus is "Buy". Our 12-month price target of $3.00 implies +219.0% from $0.94. This is research, not financial advice — always combine it with your own judgement.
The analyst consensus price target for DYAI is $3.00, about +219.0% versus the latest price of $0.94. Consensus is based on 2 analysts.
TradersQuant's 12-month model forecast for DYAI is a base case of $0.89, ranging from $0.73 (bear) to $1.11 (bull), an expected return of -5.6%. Forecasts are model estimates, not guarantees.
The TradersQuant price prediction for DYAI over the next 12 months is $0.89 in the base case (bear $0.73, bull $1.11), versus today's price of $0.94. Unlike black-box prediction sites, every TradersQuant call is logged at the price and date it was made and graded publicly against the S&P 500.
We deliberately don't publish 2030 price predictions for DYAI — no model can honestly forecast a single stock five-plus years out, and sites that do are guessing. TradersQuant focuses on a rigorous 12-month bull/base/bear range, refreshed continuously and graded on our public track record.
TradersQuant estimates DYAI's fair value at $3.00, implying +219.0% of expected upside versus the current price.
Dyadic International does not currently pay a dividend.
Data and model outputs are for research only and are not financial advice. Figures update continuously.
